Anti-Cytomegalovirus p65 antibody [CMV221] (STJ16101049)
SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG1K
ImmunogenRecombinant CMV-p65 protein
General Information
| Short Description | Mouse monoclonal anti-Cytomegalovirus p65 for use in ELISA, FC, IHC-F and IF in CMV samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | ELISA/FC/IHC-F/IF |
| Host | Mouse |
| Reactivity | CMV |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | CMV221 |
| Isotype | IgG1K |
| Conjugation | Unconjugated |
| Concentration | 100 Mu g/mL |
| Formulation | PBS with 0.02% sodium azide |
| Storage Instruction | Store at 2-8°C for up to 1-year, upon receipt. |
Target Information
| Immunogen | Recombinant CMV-p65 protein |
Additional Info
| Background | Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF) , urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Information sourced from Uniprot.org